Press release
Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)
An investigation for investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares over potential securities laws violations.
Investors who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Lexicon Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
The Woodlands, TX based Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.
On February 28, 2022, Lexicon Pharmaceuticals, Inc. announced the voluntary withdrawal of the Company's New Drug Application for its glucose regulation drug, sotagliflozin, in order to correct a technical issue with the submission that had been recently identified by the Company.
Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) declined from $3.29 per share on February 10, 2022 to as low as $1.95 per share on March 14, 2022.
Those who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) here
News-ID: 2578229 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Lexicon
Interview with Olivia Luper, Founder of Lexicon Advisor Marketing, Interviewed o …
Image: https://authoritypresswire.com/wp-content/uploads/2025/03/2021.8.5-OliviaLuper-12__1_-removebg-preview.png
Olivia Luper discusses content marketing
Listen to the interview on the Business Innovators Radio Network: Interview with Olivia Luper, Founder of Lexicon Advisor Marketing - Business Innovators Radio Network [https://businessinnovatorsradio.com/interview-with-olivia-luper-founder-of-lexicon-advisor-marketing/]
Digital content marketing has undergone a significant transformation over the years, shifting from a primary focus on quantity to an emphasis on high-quality, targeted content that resonates with specific audiences. This evolution reflects the changing landscape of consumer behavior and the…
Vocal Processor Market to Witness Stunning Growth | Major Giants Shure, Boss, Le …
The latest independent research document on "Vocal Processor Market Size, Status, Type, Application and Forecast 2024-2030" with 123+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, emerging technologies, drivers, sales, opportunities, market viewpoint and Outlook. The Study is segmented by key a region that is accelerating the marketization. Vocal Processor study is a perfect mix…
Relocation Management Software Market Is Booming Worldwide | Lexicon Relocation, …
Advance Market Analytics added research publication document on Worldwide Relocation Management Software Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Relocation Management Software market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till…
Investigation announced for Investors in Lexicon Pharmaceuticals, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Lexicon Pharmaceuticals, Inc.
Investors who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) and have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Lexicon Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
The…
Relocation Software Market Next Big Thing | Major Giants INSZoom, Lexicon Reloca …
Latest released the research study on Global Relocation Software Market, offers a detailed overview of the factors influencing the global business scope. Relocation Software Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Relocation Software. The study covers emerging player’s data, including: competitive…
“From the Elusive Muse’s Lexicon” by Garry B. Grove is published by Grosve …
ISBN #978-1839753022
“From the Elusive Muse’s Lexicon” by Garry B. Grove is published by Grosvenor House Publishing
About the Book:
From the Elusive Muse's Lexicon is a second volume of poetry to accompany the earlier, "A Storm in Pandora's Tea Box". It touches upon a diverse range of subjects, from a homage to London's beloved River Thames, a trilogy of Coventry poems anticipating the City's role as UK City of Culture…
